Mycosis fungoides in a Mexican pediatric series: Clinical, immunophenotypic, and therapeutic featuresc
##plugins.themes.themeEleven.article.main##
Palabras clave
Mycosis Fungoides, Lymphoma, T Cell, Cutaneous, Mexico, Pediatrics
Resumen
Background: Mycosis fungoides (MF) is a primary cutaneous lymphoma that in pediatric patients is frequently misdiagnosed as a benign dermatosis. Studies in Mexican children are limited.
Objective: To describe the clinical, immunophenotypic, and therapeutic characteristics of MF in a Mexican pediatric series.
Material and methods: It was conducted a cross-sectional study between 2017-2025 at a hospital in Mexico City, which included 17 pediatric patients younger than 18 years of both sexes with a diagnosis of MF.
Results: They were 13 males and 4 females, with a mean age at diagnosis of 11.9 ± 2.8 years and a median disease duration of 3 years; 52.9% of patients were referred with a diagnosis of atopic dermatitis. The most frequent clinical variant was hypopigmented (64.7%). All cases were classified as stage IB. Diagnosis required a median of 2 biopsies, with delays of up to 12 months (range 3-24). All cases showed epidermotropism with CD3 and CD4 positivity (100%), and 88.2% showed CD8 positivity. All patients received topical corticosteroids; 3 received phototherapy, 3 methotrexate, and 3 photopheresis. The classic form of MF was associated with the presence of erythematous patches and erythematous scaly plaques, as well as, in some cases, with the use of methotrexate and phototherapy.
Conclusions: Pediatric MF poses a diagnostic challenge due to its clinical similarity to common dermatoses. Although prognosis is generally favorable, its recurrence requires prolonged follow-up.
Referencias
1. Jonak C, Tittes J, Brunner PM, et al. Mycosis fungoides and Sézary syndrome. J Dtsch Dermatol Ges. 2021; 19(9):1307-34. doi: 10.1111/ddg.14610
2. Sheern C, Levell NJ, Craig PJ, et al. Mycosis fungoides: a review. Clin Exp Dermatol. 2025;50 (12):2365-75. doi:10.1093/ced/llaf341
3. Wu JH, Cohen BA, Sweren RJ. Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management. Pediatr Dermatol. 2020;37(1):18-28. doi: 10.1111/pde.14026
4. Miyashiro D, Sanches JA. Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management. Front Oncol. 2023;13:1141108. doi: 10.3389/fonc.2023.1141108
5. Kothari R, Szepietowski JC, Bagot M, et al. Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management. Int J Dermatol. 2022;61(12):1458-66. doi: 10.1111/ijd.16098.
6. Lee H. Mycosis fungoides and Sézary syndrome. Blood Res. 2023;58(S1):66-82. doi: 10.5045/br.2023.2023023
7. Rein W, Werner K. Linfoma cutáneo de linfocitos T. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatología. Barcelona, España: Elsevier; 2025. pp. 2156-2176.
8. Suh KS, Jang MS, Jung JH, et al. Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: A 29-year review. J Am Acad Dermatol. 2022;86(6):1275-84. doi: 10.1016/j.jaad.2021.06.860
9. Jung JM, Lim DJ, Won CH, et al. Mycosis Fungoides in Children and Adolescents: A Systematic Review. JAMA Dermatol. 2021;157(4):431-8. doi: 10.1001/jamadermatol.2021.0083
10. Hodak E, Amitay-Laish I, Bagot M, et al. ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part one: diagnosis and staging. Br J Dermatol. 2025;193(3):405-14. doi: 10.1093/bjd/ljaf199
11. Wen B, Zhang G, Zhan C, et al. The 2024 revision of the Declaration of Helsinki: a modern ethical framework for medical research. Postgrad Med J. 2025; 101(1194):371-82. doi: 10.1093/postmj/qgae181
12. Nagai H, Nakazawa E, Akabayashi A. The creation of the Belmont Report and its effect on ethical principles: a historical study. Monash Bioeth Rev. 2022;40(2):157-70. doi: 10.1007/s40592-022-00165-5
13. Cervini AB, Torres-Huamani AN, Sanchez-La-Rosa C, et al. Mycosis Fungoides: Experience in a Pediatric Hospital. Actas Dermosifiliogr. 2017;108(6):564-70. doi: 10.1016/j.ad.2017.01.008
14. Valencia-Ocampo OJ, Julio L, Zapata V, et al. Mycosis Fungoides in Children and Adolescents: A Series of 23 Cases. Actas Dermosifiliogr (Engl Ed). 2020;111(2):149-56. doi: 10.1016/j.ad.2019.04.004
15. De la Vega M, Dominguez MA, Morales-Sánchez MA. Mycosis Fungoides in Paediatric Patients: A Real‐Life Retrospective Study. JEADV Clinical Practice. 2025;4:783-90. doi: org/10.1002/jvc2.70059
16. Virmani P, Levin L, Myskowski PL, et al. Clinical Outcome and Prognosis of Young Patients with Mycosis Fungoides. Pediatr Dermatol. 2017;34(5):547-53. doi: 10.1111/pde.13226
17. Nasimi M, Kamyab K, Aghahi T, et al. Childhood mycosis fungoides: A clinicopathologic study of 30 cases from Iran. Australas J Dermatol. 2020;61(2):e259-61. doi: 10.1111/ajd.13192
18. Barron CR, Smoller BR. Evaluation of Melanocyte Loss in Mycosis Fungoides Using SOX10 Immunohistochemistry. Dermatopathology (Basel). 2021; 8(3):277-84. doi: 10.3390/dermatopathology8030034
19. Castano E, Glick S, Wolgast L, et al. Hypopigmented mycosis fungoides in childhood and adolescence: a long-term retrospective study. J Cutan Pathol. 2013;40(11):924-34. doi: 10.1111/cup.12217
20. Zvulunov A, Neale H, Stern J, et al. Approach to Mycosis Fungoides in children: Consensus-based recommendations. J Am Acad Dermatol. 2024; 91(6):1078-85. doi: 10.1016/j.jaad.2024.07.1501
21. Latzka J, Assaf C, Bagot M, et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023. Eur J Cancer. 2023;195:113343. doi: 10.1016/j.ejca.2023.113343
22. Talpur R, Demierre MF, Geskin L, et al. Multicenter photopheresis intervention trial in early-stage mycosis fungoides. Clin Lymphoma Myeloma Leuk. 2011; 11(2):219-27. doi: 10.1016/j.clml.2011.03.003
23. Lewis DJ, Duvic M. Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides. Dermatol Ther. 2017;30(3):1-2. doi: 10.1111/dth.12485
24. Terhaar H, Saleem M, Yusuf N. Extracorporeal Photopheresis in Dermatological Diseases. Int J Mol Sci. 2024; 25(5):3011. doi: 10.3390/ijms25053011
25. Hu ZH, Lu L, Feng JD, et al. Real-World Clinical Characteristics, Management, and Outcomes of 44 Paediatric Patients with Hypopigmented Mycosis Fungoides. Acta Derm Venereol. 2023;103:adv6226. doi: 10.2340/actadv.v103.6226
26. Hodak E, Amitay-Laish I, Bagot M, et al. ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part two: treatment. Br J Dermatol. 2025;193(4):653-61. doi: 10.1093/bjd/ljaf198
##plugins.themes.themeEleven.article.sidebar##
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Los autores conservan sus derechos de autor y otorgan a la Revista Médica del IMSS el derecho de primera publicación. Los artículos se distribuyen bajo una Licencia Creative Commons Atribución-NoComercial-SinDerivar 4.0 Internacional, que permite su difusión siempre que se reconozca al autor y la fuente original.